Figure 1: Schematic of next-generation sequencing and ctDNA analyses. | Nature Communications

Figure 1: Schematic of next-generation sequencing and ctDNA analyses.

From: Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients

Figure 1

Next-generation sequencing analyses were performed for tumour specimens obtained from pancreatic ductal adenocarcinoma patients using either whole-exome or targeted analyses focused on 116 genes. Genomic alterations were evaluated for potential clinical utility or as prognostic indicators. Somatic mutations identified through genomic analyses were used to evaluate patient plasma for detection of ctDNA at the time of diagnosis or after surgical intervention.

Back to article page